NeuroVista Receives $16,500,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    100 Fourth Ave North Seattle, WA 98109
  • Company Description
    NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy. Epilepsy is a neurological condition affecting approximately 1% of the U.S. population – more than Parkinson’s disease, multiple sclerosis and Lou Gehrig’s disease combined.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    GBS Venture Partners
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    Foundation Medical Partners